CG Oncology, Inc.
CGON
$75.03
$0.320.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -75.18% | -76.91% | -82.87% | -108.09% | -104.82% |
| Total Depreciation and Amortization | 1,370.65% | 4,250.00% | 4,415.63% | 1,555.56% | 957.89% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 147.72% | 141.97% | 290.23% | 4,494.83% | 1,526.50% |
| Change in Net Operating Assets | -89.97% | -133.74% | -21.68% | 1,774.79% | 803.53% |
| Cash from Operations | -90.23% | -95.19% | -68.14% | -60.66% | -41.80% |
| Capital Expenditure | -268.07% | -77.31% | 42.74% | -1,244.00% | -720.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -140.51% | -106.56% | 25.56% | 53.70% | 54.96% |
| Cash from Investing | -156.14% | -118.72% | 18.27% | 46.17% | 54.89% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | 142.40% | 141.43% | -75.65% | -31.96% | -44.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 108.23% | 51.30% | 90.77% | 95.79% | 91.68% |
| Cash from Financing | 142.92% | 141.58% | -75.55% | -30.86% | -42.39% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 147.58% | 78.41% | -190.26% | -94.77% | -207.13% |